Compare KB & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KB | HLN |
|---|---|---|
| Founded | 2008 | 2022 |
| Country | South Korea | United Kingdom |
| Employees | N/A | 24524 |
| Industry | Commercial Banks | Package Goods/Cosmetics |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.3B | 41.1B |
| IPO Year | 2008 | N/A |
| Metric | KB | HLN |
|---|---|---|
| Price | $106.95 | $8.96 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 221.8K | ★ 9.3M |
| Earning Date | 04-23-2026 | 02-26-2026 |
| Dividend Yield | ★ 2.31% | 1.94% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $18.22 | $6.55 |
| Revenue Next Year | $3.21 | $4.42 |
| P/E Ratio | ★ $9.90 | $49.05 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $76.31 | $8.65 |
| 52 Week High | $119.71 | $11.28 |
| Indicator | KB | HLN |
|---|---|---|
| Relative Strength Index (RSI) | 51.26 | 45.25 |
| Support Level | $105.51 | $8.75 |
| Resistance Level | $109.70 | $9.29 |
| Average True Range (ATR) | 2.61 | 0.14 |
| MACD | 0.64 | 0.01 |
| Stochastic Oscillator | 44.97 | 56.36 |
KB Financial Group Inc. is a financial holding company in Korea. The company operations include Kookmin Bank, one of the commercial banks in Korea. The company's subsidiaries collectively engage in a broad range of businesses, including commercial banking, credit cards, asset management, non-life and life insurance, capital markets activities, and international banking and finance. The company's segments include the Banking business, Securities business, Non-life Insurance business, Credit card business, and Life Insurance business. The Group generates the majority of its revenue from the Banking business.
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.